{'fraction_non_alphanumeric': 0.012012012012012012, 'fraction_numerical': 0.0015015015015015015, 'mean_word_length': 6.095744680851064, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Detecting microalbuminuria and taking action in the cardiometabolic syndrome and type 2 diabetes mellitus.

Microalbuminuria is an early indicator of cardiac and renal vascular endothelial damage in individuals with diabetes mellitus, impaired glucose tolerance, hypertension, and the CardioMetabolic Syndrome. This simple, inexpensive dipstick screening test is not only associated with an increased risk of progressive renal insufficiency but also with an increased risk of cardiovascular disease and events. Regular screening for microalbuminuria will allow for early detection and intervention to prevent renal and vascular complications of these disease states.